Yannick Vermeiren Selected Research

Methoxyhydroxyphenylglycol

1/2019	Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
1/2018	Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis.
1/2015	Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome.
1/2014	Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yannick Vermeiren Research Topics

Disease

14	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 10/2011
12	Dementia (Dementias) 12/2021 - 09/2013
4	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2018
4	Down Syndrome (Down's Syndrome) 10/2018 - 01/2015
3	Cognitive Dysfunction 01/2022 - 12/2015
2	Frontotemporal Dementia (Semantic Dementia) 01/2018 - 01/2016
1	Amyloid Plaque 11/2022
1	Emergence Delirium 01/2022
1	Disease Progression 01/2022
1	Delirium 01/2022
1	Lewy Body Disease (Lewy Body Dementia) 12/2021
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Synucleinopathies 01/2020
1	Neuroinflammatory Diseases 12/2019
1	Movement Disorders (Movement Disorder) 01/2018
1	Aneuploidy (Aneuploid) 09/2017
1	Neurobehavioral Manifestations 01/2016
1	Psychotic Disorders (Schizoaffective Disorder) 01/2015
1	Hallucinations (Hallucination) 01/2014
1	Phobic Disorders (Phobia) 09/2013

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 11/2022 - 10/2011
6	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 01/2014
6	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 09/2013
4	Amyloid (Amyloid Fibrils)IBA 11/2022 - 01/2015
4	MethoxyhydroxyphenylglycolIBA 01/2019 - 01/2014
3	Amino Acids FDA Link 11/2022 - 09/2013
3	Peptides (Polypeptides)IBA 11/2022 - 01/2015
3	Hydroxyindoleacetic AcidIBA 01/2022 - 09/2013
2	Threonine (L-Threonine)FDA Link 11/2022 - 01/2018
2	AcidsIBA 01/2022 - 01/2019
2	SynucleinsIBA 12/2021 - 01/2020
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020 - 01/2018
2	Homovanillic AcidIBA 01/2019 - 09/2013
2	Biogenic Amines (Biogenic Amine)IBA 01/2015 - 09/2013
1	tau Proteins (tau Protein)IBA 11/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	NeurograninIBA 12/2021
1	MelatoninIBA 01/2021
1	CatecholaminesIBA 01/2020
1	KynurenineIBA 12/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	3,4-Dihydroxyphenylacetic AcidIBA 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Lipocalin-2IBA 01/2017
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2016
1	Taurine FDA Link 09/2013
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 10/2011

Therapy/Procedure

1	Sympathectomy (Sympathectomies) 01/2020
1	Therapeutics 10/2018
1	Institutionalization (Institutionalized Persons) 12/2015